Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 6,000 | 4,970 | 4,875 | 3,416 | 4,770 |
| Operating Income | -6,000 | -4,970 | -4,875 | -3,416 | -4,770 |
| Other Income | -1,826 | 2,624 | -3,734 | -887 | 7 |
| Pre-tax Income | -7,826 | -2,345 | -8,608 | -4,303 | -4,762 |
| Net Income Continuous | -7,826 | -2,345 | -8,608 | -4,303 | -4,762 |
| Net Income | $-7,826 | $-2,345 | $-8,608 | $-4,303 | $-4,762 |
| EPS Basic Total Ops | -0.11 | -0.04 | -0.15 | -0.07 | -0.08 |
| EPS Basic Continuous Ops | -0.11 | -0.04 | -0.15 | -0.07 | -0.08 |
| EPS Diluted Total Ops | -0.11 | -0.04 | -0.15 | -0.07 | -0.08 |
| EPS Diluted Continuous Ops | -0.11 | -0.04 | -0.15 | -0.07 | -0.08 |
| EBITDA(a) | $-5,985 | $-4,931 | $-8,570 | $-4,266 | $-4,735 |